Dominant-negative Effect of the C-fos Family Gene Products on Inducible NO Synthase Expression in Macrophages
Overview
Affiliations
Activation of murine peritoneal macrophages or the macrophage cell line RAW264 with IFN-gamma and bacterial lipopolysaccharide promotes a transient up-regulation of c-fos family gene expression following inducible NO synthase (iNOS) production. Since introduction of a double mutation into the two AP-1-binding sites in the iNOS promoter region reduced the promoter activity to 25% of the authentic one in activated RAW264 cells, the induced c-Fos/AP-1 may promote iNOS expression in activated macrophages. Surprisingly, overexpression of c-fos in activated macrophages completely suppressed the production of iNOS, but not that of IL-6 and IL-1beta. The regulatory effect was also observed by overexpression of c-fos, c-jun or fosB on the promoter activity as deduced from transfection experiments. However, the mutation of AP-1-binding sites in the promoter region did not abrogate the regulatory effect of c-fos and the effect of c-fos was diminished by co-transfection with c-jun, but not with fosB, suggesting no relation between the regulatory effect and a c-Fos/AP-1 complex. Expression of NF-IL6 (C/EBPbeta), whose gene product can make a non-functional heterodimer with c-Fos family proteins, was transiently induced in activated macrophages. Overexpression of NF-IL6 in activated RAW264 cells augmented iNOS promoter activity and reduced the regulatory effect of c-fos overexpression. Thus, overproduction of c-Fos family proteins acts as a dominant-negative-type regulator on iNOS expression in activated macrophages.
Profiling Microglia in a Mouse Model of Machado-Joseph Disease.
Campos A, Duarte-Silva S, Fernandes B, das Neves S, Marques F, Teixeira-Castro A Biomedicines. 2022; 10(2).
PMID: 35203447 PMC: 8869404. DOI: 10.3390/biomedicines10020237.
Redweik G, Kogut M, Arsenault R, Lyte M, Mellata M Commun Biol. 2021; 4(1):1359.
PMID: 34862463 PMC: 8642538. DOI: 10.1038/s42003-021-02888-3.
Ahmadi E, Zabihi M, Hosseinzadeh R, Mohamed Khosroshahi L, Noorbakhsh F PLoS One. 2021; 16(12):e0260360.
PMID: 34855795 PMC: 8639087. DOI: 10.1371/journal.pone.0260360.
Veremeyko T, Yung A, Dukhinova M, Strekalova T, Ponomarev E Front Cell Neurosci. 2019; 13:453.
PMID: 31680868 PMC: 6798237. DOI: 10.3389/fncel.2019.00453.
Hannemann N, Cao S, Eriksson D, Schnelzer A, Jordan J, Eberhardt M J Clin Invest. 2019; 129(7):2669-2684.
PMID: 30990796 PMC: 6597220. DOI: 10.1172/JCI96832.